KFAS
BSX icon

Keating Financial Advisory Services’s Boston Scientific BSX Stock Holding History

Keating Financial Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.7K Buy
1,094
+238
+28% +$12.9K 0.01% 696
2026
Q1 		$53.7K Sell
856
-353
-29% -$28.2K 0.01% 601
2025
Q4 		$115K Buy
+1,209
New +$119K 0.02% 473

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Keating Financial Advisory Services's BSX Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Boston Scientific (BSX) stake by 28% in Q2 2026, buying an estimated $12.9K and bringing the position to 1,094 shares worth $46.7K. The position accounts for 0.01% of the portfolio, ranked #696.

Keating Financial Advisory Services first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $115K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Keating Financial Advisory Services held 1,094 shares of Boston Scientific worth $46.7K as of Q2 2026.
  • Keating Financial Advisory Services bought 238 Boston Scientific shares in Q2 2026, an estimated $12.9K.
  • Boston Scientific made up 0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #696 holding.
  • Keating Financial Advisory Services first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Boston Scientific position peaked at $115K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.